Andrew F. Brouwer

Andrew F. Brouwer

Auto-generated profile, based on publicly available information

Andrew F. Brouwer

Department of Epidemiology, University of Michigan, Ann Arbor, MI, United States

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ABAndrew F. Brouwer
Andrew F. Brouwer
JEJoseph Eisenberg
Joseph Eisenberg
CPConnor D. Pomeroy
Connor D. Pomeroy
LSLester M. Shulman
Lester M. Shulman
MHMusa Hindiyeh
Musa Hindiyeh
MEMarisa C. Eisenberg
Marisa C. Eisenberg
Significance: The 2013–2014 silent polio epidemic in Israel was a setback to global eradication efforts because Israel had previously been certified as polio-free by the World Health Organization. Fortunately, Israel has a robust environmental surveillance program that detected the epidemic and allowed rapid mobilization of a vaccine campaign before any cases of acute flaccid paralysis. This kind of silent (caseless) epidemic will be increasingly common as we approach global eradication, demonstrating the need for both enhanced environmental surveillance and an accompanying inference framework to translate environmental data into public health metrics. We incorporate environmental data into a population-level disease transmission model, generating insights into the epidemiology of the outbreak. This framework can be used to guide future interventions.

1 March 2022 in Annals of Internal Medicine
Verified
Journal Article
Closed access
MRMarc D. Ryser
Marc D. Ryser
JLJane Lange
Jane Lange
LILurdes Y.T. Inoue
Lurdes Y.T. Inoue
EOEllen S. O’mEara
Ellen S. O’mEara
CGCharlotte Gard
Charlotte Gard
RERuth B. Etzioni
Ruth B. Etzioni
Overdiagnosis from screening can result from the detection of indolent preclinical cancer or progressive preclinical cancer where the person would have died of an unrelated cause before clinical di... Visual Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort. Overdiagnosis from screening can result from the detection of indolent preclinical cancer or progressive... Background: Mammography screening can lead to overdiagnosis—that is, screen-detected breast cancer that would not have caused symptoms or signs in the remaining lifetime. There is no consensus abou...

7 April 2017 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
ABAndrew F Brouwer
Andrew F Brouwer
MWMark Weir
Mark Weir
MEMarisa C Eisenberg
Marisa C Eisenberg
RMRafael Meza
Rafael Meza
JEJoseph N S Eisenberg
Joseph N S Eisenberg
Environmentally mediated infectious disease transmission models provide a mechanistic approach to examining environmental interventions for outbreaks, such as water treatment or surface decontamination. The shift from the classical SIR framework to one incorporating the environment requires codifying the relationship between exposure to environmental pathogens and infection, i.e. the dose–response relationship. Much of the work characterizing the functional forms of dose–response relationships has used statistical fit to experimental data. However, there has been little research examining the consequences of the choice of functional form in the context of transmission dynamics. To this end, we identify four properties of dose–response functions that should be considered when selecting a functional form: low-dose linearity, scalability, concavity, and whether it is a single-hit model. We find that i) middle- and high-dose data do not constrain the low-dose response, and different dose–response forms that are equally plausible given the data can lead to significant differences in simulated outbreak dynamics; ii) the choice of how to aggregate continuous exposure into discrete doses can impact the modeled force of infection; iii) low-dose linear, concave functions allow the basic reproduction number to control global dynamics; and iv) identifiability analysis offers a way to manage multiple sources of uncertainty and leverage environmental monitoring to make inference about infectivity. By applying an environmentally mediated infectious disease model to the 1993 Milwaukee Cryptosporidium outbreak, we demonstrate that environmental monitoring allows for inference regarding the infectivity of the pathogen and thus improves our ability to identify outbreak characteristics such as pathogen strain. Many infectious disease interventions, including water treatment, hand hygiene, and surface decontamination, target pathogens in the environment. Explicitly modeling the concentration of pathogens in the environment within transmission models can be a useful way to consider not only the impact of such mitigation efforts but also the spatial spread of pathogens and sampling strategies for environmental monitoring. However, we need to understand the dose–response relationship, that is, how exposure to pathogens translates into a probability of infection. The field of quantitative microbial risk assessment has developed dose–response models from experimental data, but little work has been done to assess the impact the choice of dose–response model has on transmission model dynamics. We show that dynamics of simulated transmission models incorporating a dose–response model that has been fit to experimental data can vary widely despite little statistical difference in the fit to the experimental dose–response data. This and other results allow us to give specific guidance for the use of dose–response functions in a transmission modeling context. We also underscore the usefulness of environmentally mediated transmission models by demonstrating how environmental monitoring data can be used to provide new information about pathogen strain.

16 November 2020 in Tobacco Control
Verified
Journal Article
Open access
PDF file
ABAndrew F Brouwer
Andrew F Brouwer
JJJihyoun Jeon
Jihyoun Jeon
JHJana L Hirschtick
Jana L Hirschtick
EJEvelyn Jimenez-Mendoza
Evelyn Jimenez-Mendoza
RMRitesh Mistry
Ritesh Mistry
RMRafael Meza
Rafael Meza
Introduction Even prior to 2018, electronic nicotine delivery systems (ENDS) began to dramatically change the landscape of tobacco products and product use patterns in the USA. Methods Using a Markov multistate transition model accounting for complex survey design, transition rates between never, non-current, cigarette, ENDS and dual use states were estimated for 23 253 adult participants in waves 1–4 (approximately 2013–2017) of the Population Assessment of Tobacco and Health study. We made short-term transition projections and estimated HRs for age, sex, race/ethnicity, education and income. Results Cigarette use was persistent among adults, with 89.7% (95% CI 89.1% to 90.3%) of exclusive cigarette users and 86.1% (95% CI 84.4% to 87.9%) of dual users remaining cigarette users (either exclusive or dual) after one wave. In contrast, ENDS use was less persistent, with 72.1% (95% CI 69.6% to 74.6%) of exclusive ENDS users and 50.5% (95% CI 47.8% to 53.3%) of dual users remaining ENDS users (with or without cigarettes) after one wave. Exclusive ENDS users were more likely to start cigarette use after one wave than either never users (HR 25.2; 95% CI 20.9 to 30.5) or non-current users (HR 5.0; 95% CI 4.3 to 5.8). Dual users of ENDS and cigarettes were more likely to stop using cigarettes than exclusive cigarette users (HR 1.9; 95% CI 1.6 to 2.3). Transition rates varied among sociodemographic groups. Conclusions Multistate transition models are an effective tool for uncovering and characterising longitudinal patterns and determinants of tobacco use from complex survey data. ENDS use among US adults was less persistent than cigarette use prior to 2018.

25 June 2019 in BMC Public Health
Verified
Journal Article
Open access
PDF file
ABAndrew F. Brouwer
Andrew F. Brouwer
RDRachel L. Delinger
Rachel L. Delinger
MEMarisa C. Eisenberg
Marisa C. Eisenberg
LCLora P. Campredon
Lora P. Campredon
HWHeather M. Walline
Heather M. Walline
RMRafael Meza
Rafael Meza
The human papillomavirus (HPV) is the most common sexually transmitted infection and is linked to several types of cancer. HPV vaccination uptake in the U.S. is relatively low, despite the vaccine’s high efficacy. Some parents of adolescents have concerns that vaccination will encourage sexual behavior and therefore choose not to vaccinate. Previous studies investigating vaccination and sexual behavior have included only young women and girls. The objective of this study is to assess associations between HPV-vaccination and sexual behavior in a college-age cohort of both men and women. We analyzed questionnaire data collected from the Michigan HPV and Oropharyngeal Cancer Study, a cohort study designed to investigate HPV infection and its association with sexual behavior (data collected 2015–17, Ann Arbor, MI). Here, we consider vaccination status, sexual behavior, and substance use among 241 college-aged men and women. Logistic, Poisson, and Cox regression were used to determine the relationship between probability of sexual debut, number of sexual partners, and HPV vaccination status at baseline as well as between age at sexual debut and vaccination status at debut. HPV vaccination status was not significantly associated with an increased likelihood of sexual debut (odds ratio: 0.80 (95% CI: 0.41–1.58), decreased age of sexual debut (hazard ratio: 0.81 (95% CI: 0.65–1.00), nor an increased number of sexual partners (per year sexually active; incidence rate ratio: 1.27 (95% CI: 0.86–1.87)) in this cohort, after controlling for age, race, sex, and substance use. Instead, race or alcohol use were independent predictors of sexual behavior. Concerns about the influence of the HPV vaccine on sexual behavior are likely unfounded for both men and women. These results can aid in increasing vaccine acceptability, inform and strengthen physician recommendations, and ultimately reduce the burden of HPV and HPV-related cancers in the U.S.

8 February 2017 in Environmental Science & Technology
Verified
Journal Article
Open access
ABAndrew F. Brouwer
Andrew F. Brouwer
MEMarisa C. Eisenberg
Marisa C. Eisenberg
JRJustin Remais
Justin Remais
PCPhilip A. Collender
Philip A. Collender
RMRafael Meza
Rafael Meza
JEJoseph N. S. Eisenberg
Joseph N. S. Eisenberg
As the appreciation for the importance of the environment in infectious disease transmission has grown, so too has interest in pathogen fate and transport. Fate has been traditionally described by simple exponential decay, but there is increasing recognition that some pathogens demonstrate a biphasic pattern of decay—fast followed by slow. While many have attributed this behavior to population heterogeneity, we demonstrate that biphasic dynamics can arise through a number of plausible mechanisms. We examine the identifiability of a general model encompassing three such mechanisms: population heterogeneity, hardening off, and the existence of viable-but-not-culturable states. Although the models are not fully identifiable from longitudinal sampling studies of pathogen concentrations, we use a differential algebra approach to determine identifiable parameter combinations. Through case studies using Cryptosporidium and Escherichia coli, we show that failure to consider biphasic pathogen dynamics can lead to substantial under- or overestimation of disease risks and pathogen concentrations, depending on the context. More reliable models for environmental hazards and human health risks are possible with an improved understanding of the conditions in which biphasic die-off is expected. Understanding the mechanisms of pathogen decay will ultimately enhance our control efforts to mitigate exposure to environmental contamination.